文献速递泌尿系结石

PCN与JJ支架治疗梗阻性尿石症的成本效果:STONE随机试验经济学评价

Cost-effectiveness of percutaneous nephrostomy vs JJ stent in obstructive urolithiasis: economic evaluation alongside the STent Or NEphrostomy (STONE) randomised controlled trial.
PubMed 文献 · BJU Int · 2026-03-13

基于STONE随机对照非劣效试验的204例梗阻性尿石症需减压患者,从社会视角比较经皮肾穿刺造瘘(PCN)与JJ输尿管支架的成本效果。结果显示JJ支架手术成本更高(€792 vs €685),但总社会成本更低(€7122 vs €8468),且恢复时间和QALYs相似,JJ支架在€0支付意愿阈值下具有成本效果的概率为0.74。

要点

  • JJ支架总社会成本低于PCN(€7122 vs €8468),差异主要来自生产力损失和家庭照护。
  • 两组恢复时间和QALYs相似,JJ支架在€0阈值下成本效果概率为0.74。
  • 等待 definitive 取石期间的社会成本占比最大,缩短等待时间或可降低总成本。

核心结论

  • JJ输尿管支架虽手术成本更高,但相比PCN更可能具有成本效果。

研究设计与样本

  • 随机对照非劣效试验,纳入204例需减压的梗阻性尿石症患者,随机分配至PCN或JJ支架,随访至结石手术取出或自行排出。

主要发现

  • PCN加权平均手术成本为€685,JJ支架为€792。
  • PCN平均总社会成本为€8468,JJ支架为€7122。
  • 成本差异最大项为生产力损失和家庭照护。
  • 两组恢复时间和QALYs相似。
  • 在€0支付意愿阈值下,JJ支架相比PCN具有成本效果的概率:更快恢复时间为0.74,QALYs为0.74。

临床怎么用

  • 在荷兰医疗体系中,JJ支架可作为梗阻性尿石症减压的优先成本效果选择。
  • 在手术室外进行操作可降低手术成本。
  • 缩短取石等待时间可能降低总社会成本。

局限性

  • 部分成本和生活质量数据为患者自报。
  • 分析基于荷兰医疗体系,外推性可能受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate whether percutaneous nephrostomy (PCN) is cost-effective compared to JJ ureteric stent in the acute treatment of obstructive urolithiasis. PATIENTS AND METHODS: A randomised controlled non-inferiority trial with 204 patients with obstructive urolithiasis requiring decompression. Participants were randomly assigned to either PCN or JJ stent, with follow-up until the stone was surgically removed or passed spontaneously. Effectiveness outcomes included time to recovery and quality-adjusted life years (QALYs). Costs were assessed from a societal perspective, incorporating healthcare, patient-related, and lost productivity costs. RESULTS: Weighted mean procedure costs were €685 for PCN and €792 for JJ. Mean total societal costs were €8468 for PCN and €7122 for JJ. Largest cost differences were in productivity loss and home care. Time to recovery and QALYs were similar between groups. The probability that JJ was cost-effective compared to PCN was 0.74 for quicker recovery time and 0.74 for QALYs at a willingness-to-pay threshold of €0. Some cost and quality-of-life data were self-reported, and the analysis reflects the Dutch healthcare system, which may limit generalisability. CONCLUSION: The JJ ureteric stent was found to be the likely cost-effective option compared to PCN, despite higher procedural costs. Procedural costs can be lowered by performing procedures outside of an operating theatre. Most societal costs were made during the waiting period for definitive stone removal; future research should investigate whether total cost can be lowered by reducing waiting times.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Schuil HW, Hendriks N, El Alili M, et al. Cost-effectiveness of percutaneous nephrostomy vs JJ stent in obstructive urolithiasis: economic evaluation alongside the STent Or NEphrostomy (STONE) randomised controlled trial. BJU Int. 2026. PMID: 41830115. doi:10.1111/bju.70218

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。